Table 1.
Patient characteristics.
| Variable | Total SSC n = 1307 (%) |
Matched SSC n = 481 (%) |
2020 VLC n = 108 (%) |
p-Value | 2016 VLC n = 400 (%) |
p-Value |
|---|---|---|---|---|---|---|
| Age: | ||||||
| Overall mean (SD) | 61 yr (19.2) | 55 yr (21.0) | 59 yr (16.1) | <0.001 | 55 yr (21.0) | <0.001 |
| 0–9 years | 25 (2) | 11 (2) | 1 (1) | 11 (3) | ||
| 10–19 years | 35 (3) | 23 (5) | 1 (1) | 19 (5) | ||
| 20–29 years | 55 (4) | 32 (7) | 3 (3) | 27 (7) | ||
| 30–39 years | 73 (6) | 45 (9) | 7 (6) | 33 (8) | ||
| 40–49 years | 116 (9) | 60 (12) | 13 (12) | 50 (13) | ||
| 50–59 years | 216 (17) | 73 (15) | 26 (24) | 57 (14) | ||
| 60–69 years | 306 (23) | 100 (21) | 30 (28) | 89 (22) | ||
| 70–79 years | 292 (22) | 86 (18) | 18 (17) | 78 (20) | ||
| 80–89 years | 163 (12) | 41 (9) | 7 (6) | 31 (8) | ||
| 90+ years | 38 (3) | 10 (2) | 2 (2) | 5 (1) | ||
| Sex: | ||||||
| Female | 738 (56) | 309 (64) | 64 (59) | 254 (64) | ||
| Male | 569 (44) | 172 (36) | 44 (41) | 146 (37) | ||
| 0.57 | 0.01 | |||||
| Ethnicity: | ||||||
| New Zealand European | 1096 (84) | 378 (78) | 80 (74) | 317 (79) | ||
| Maori | 73 (6) | 30 (6) | 12 (11) | 26 (7) | ||
| Pasifika | 12 (1) | 4 (1) | 1 (1) | 2 (1) | ||
| European, other | 82 (6) | 50 (10) | 11 (10) | 42 (11) | ||
| Asian | 22 (2) | 14 (3) | 2 (2) | 9 (2) | ||
| Other | 22 (2) | 5 (1) | 2 (2) | 4 (1) | ||
| 0.13 | 0.04 | |||||
| Patient Location: | ||||||
| Urban | 770 (59) | 290 (60) | 37 (35) | 211 (53) | ||
| Semi-rural | 481 (37) | 171 (36) | 64 (60) | 169 (42) | ||
| Rural | 55 (4) | 19 (4) | 6 (6) | 20 (5) | ||
| <0.01 | 0.10 | |||||
| Referrer location: | ||||||
| Urban | 798 (61) | 303 (63) | 35 (33) | 216 (54) | ||
| Semi-rural | 473 (36) | 171 (32) | 66 (62) | 175 (44) | ||
| Rural | 20 (2) | 8 (2) | 5 (5) | 9 (2) | ||
| <0.01 | 0.02 | |||||
SSC—suspected skin cancer pathway; VLC—virtual lesion clinic; yr—years; SD—standard deviation.